HEALTH2VALUE

Advisory for Life & Sciences

Bridging Health, Quantitative Modeling & Business Strategy

“Where complex biological systems meet quantitative rigor and strategic impact.”

Independent Science. Strategic Insight.

Connecting scientific knowledge, complex systems thinking, and strategic decision-making.

At Health2Value, I believe that the value of science lies not only in generating knowledge, but in connecting insights across disciplines and translating them into meaningful action.

With a background in chemistry, biophysics, and microbiome research, and over two decades of experience in academia and industry, I bring independent scientific judgment and strategic perspective to complex challenges in health, life sciences, and sustainability.

My approach combines scientific rigor, quantitative reasoning, and interdisciplinary thinking to identify opportunities, challenge assumptions, and create value.

Core Focus Areas

  • Scientific Strategy & Independent Advisory
    Providing independent scientific expertise and strategic counsel to businesses, investors, and research organizations, bridging scientific evidence, innovation, and decision-making.
  • Microbiome, Human Health & One Health
    Exploring the interactions between microbiota, human health, nutrition, lifestyle, and the environment, connecting biological insights with broader health and sustainability challenges.
  • Research, Data & Complex Systems
    Integrating scientific research, quantitative analysis, and systems thinking to understand complex biological processes, identify critical relationships, and develop new perspectives.
  • Scientific Communication & Thought Leadership
    Translating complex science into meaningful insights through invited lectures, publications, interdisciplinary dialogue, and expert advisory activities.

Health2Value connects scientific independence, intellectual curiosity, and strategic expertise — turning knowledge into insight, and insight into value.

Endorsements

“I got to know Olaf Larsen through our shared past. During our collaboration, I was immediately struck by how thorough Olaf is in methodology and statistics. He combines this substantive expertise with a high degree of emotional intelligence: he is a true people person who is a good listener and collaborator. Olaf is characterized by integrity, meticulousness, and decisiveness. He adheres to clear principles: right is right and wrong is wrong. He is honest, says what needs to be said, and acts consistently based on mutual respect. In short: a reliable, knowledgeable, and ethical professional with whom it is pleasant and efficient to work.”

Prof. dr. Herman Pieterse

CEO, Profess Medical Consultancy BV

About Dr. Olaf Larsen

Dr. Olaf F. A. Larsen holds an MSc in Chemistry and a PhD in Physics (Biophysics). He combines over two decades of corporate scientific leadership with academic roles as Assistant Professor at VU University Amsterdam and affiliated research. Author of over 40 peer-reviewed scientific publications on gut microbiota, nutritional modeling, and health economics.

Selected key publications (out of 40+)

Nutritional Life Cycle Assessment (QI-nLCA)

  • Focus: Methodological framework combining environmental impact metrics of foodstuffs with nutritional value.
  • Paper: van Eijsden, M., Peters, S., Larsen, O. F. A., Geurts, J. M., & Huppertz, T. (2025). Combining nutritional value with environmental impact: a novel approach to nutritional life cycle assessment. The International Journal of Life Cycle Assessment, 30(9), 1987-2002.

Microbiota Diversity & Mechanistic Health Links

  • Focus: Establishing mechanistic and causal frameworks between gut microbiota diversity and health outcomes.
  • Paper: Larsen, O. F. A., & Claassen, E. (2018). The mechanistic link between health and gut microbiota diversity. Scientific Reports, 8(1), 2183.

Intraindividual Variation & Trial Methodology

  • Focus: Addressing individual biological baseline variations to improve the statistical power and methodological rigor of clinical (nutritional) studies.
  • Paper: Larsen, O. F. A., Claassen, E., & Brummer, R. J. (2020). On the importance of intraindividual variation in nutritional research. Beneficial Microbes, 11(6), 511-518.

Health Economics & Clinical Nutrition (HEOR)

  • Focus: Translating clinical health benefits into economic value modeling to quantify healthcare cost reductions and market viability.
  • Paper: Flach, J., Koks, M., Van der Waal, M. B., Claassen, E., & Larsen, O. F. A. (2018). Economic potential of probiotic supplementation in institutionalized elderly with chronic constipation. PharmaNutrition, 6(4), 198-206.

Microbiota, Epidemiology & Chronic Disease Systems

  • Focus: Mapping the critical role of the gut microbiota across the epidemiology of infectious, autoimmune, and metabolic conditions.
  • Paper: Larsen, O. F. A., van der Grint, M., Wiegers, C., & van de Burgwal, L. H. (2022). The gut microbiota: master of puppets connecting the epidemiology of infectious, autoimmune, and metabolic disease. Frontiers in Microbiology, 13, 902106.

Connect & Collaborate

For strategic inquiries, speaking engagements, or advisory projects: